IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Acta Oncologica

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.36

h-Index

2022-2023

 112

Rank

2022-2023

 4517

SJR

2022-2023

 0.957

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Acta Oncologica
Abbreviation Acta Oncol.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Hematology (Q2); Oncology (Q2)
h-index 112
Overall Rank/Ranking 4517
SCImago Journal Rank (SJR) 0.957
Impact Score 2.36
Publisher Informa Healthcare
Country United Kingdom
ISSN 1651226X, 0284186X
Best Quartile Q1
Coverage History 1963-1966, 1968-2022




Aim and Scope


Acta Oncologica is one of the leading journals in clinical oncology and related disciplines, and accepts articles within all fields of cancer research from applied basic research to cancer nursing and psychological aspects of cancer. Articles on tumour pathology, experimental oncology and biology, cancer epidemiology and medical radiophysics are welcomed if they have a clinical aim or interest. Besides submitted specific articles, review articles are published regularly. Special material may also be published as supplements. Acta Oncologica is published in association with the five Nordic oncological societies. The journal has subscribers in more than 50 countries.


About Acta Oncologica


Acta Oncologica is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Hematology (Q2); Oncology (Q2). It is published by Informa Healthcare. The overall rank of Acta Oncologica is 4517. According to SCImago Journal Rank (SJR), this journal is ranked 0.957. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 112. The best quartile for this journal is Q1.

The ISSN of Acta Oncologica journal is 1651226X, 0284186X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Acta Oncologica is cited by a total of 2173 articles during the last 3 years (Preceding 2022).


Acta Oncologica Impact IF 2022-2023


The Impact IF 2022 of Acta Oncologica is 2.36, which is computed in 2023 as per its definition. Acta Oncologica IF is decreased by a factor of 0.47 and approximate percentage change is -16.61% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Acta Oncologica Impact IF 2023 Prediction


Impact IF 2022 of Acta Oncologica is 2.36. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Acta Oncologica. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.36
2021 2.83
2020 2.74
2019 3.07
2018 2.70
2017 2.93
2016 2.65
2015 3.29
2014 2.55

Acta Oncologica h-index


  Table Setting

Acta Oncologica has an h-index of 112. It means 112 articles of this journal have more than 112 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Acta Oncologica ISSN


The ISSN of Acta Oncologica is 1651226X, 0284186X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Acta Oncologica Rank and SCImago Journal Rank (SJR)


The overall rank of Acta Oncologica is 4517. According to SCImago Journal Rank (SJR), this journal is ranked 0.957. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Acta Oncologica by Year


Year SJR
2023/2024 Coming Soon
2022 0.957
2021 0.939
2020 1.174
2019 1.210
2018 1.222
2017 1.400
2016 1.407
2015 1.543
2014 1.256

Ranking of Acta Oncologica by Year


Year Ranking
2023/2024 Coming Soon
2022 4517
2021 4483
2020 3417
2019 3203
2018 3225
2017 2596
2016 2644
2015 2264
2014 3080

Acta Oncologica Publisher


Table Setting

Acta Oncologica is published by Informa Healthcare. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1963-1966, 1968-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Acta Oncologica is Acta Oncol.. This abbreviation ('Acta Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Acta Oncologica


If your research field is/are related to Medicine (miscellaneous) (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Hematology (Q2); Oncology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Acta Oncologica?

Acta Oncologica latest impact IF is 2.36. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.29 (2015) and 2.36 (2022), respectively, in the last 9 years. Moreover, its average IS is 2.79 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Acta Oncologica?

The Acta Oncologica has an SJR (SCImago Journal Rank) of 0.957, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.543 in 2015 and the lowest being 0.939 in 2021. Furthermore, the average SJR of the Acta Oncologica over the previous 9-year period stands at 2.79.


What's the latest h-index of the Acta Oncologica?

The latest h-index of the Acta Oncologica is 112.


Who's the publisher of the Acta Oncologica?

The Acta Oncologica is published by the Informa Healthcare, with its country of publication being the United Kingdom.


What's the current ranking of the Acta Oncologica?

The Acta Oncologica is currently ranked 4517 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2264 in 2015 and its lowest position of 4517 in 2022.


What's the abbreviation or short name for the Acta Oncologica?

The standard ISO4 abbreviation for the Acta Oncologica is Acta Oncol..


Is the "Acta Oncologica" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Acta Oncologica is classified as a journal that the Informa Healthcare publishes.


What's the scope or major areas of the Acta Oncologica?

The Acta Oncologica encompasses the following areas:

  • Medicine (miscellaneous)
  • Radiology, Nuclear Medicine and Imaging
  • Hematology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Acta Oncologica?

The Acta Oncologica is assigned the following International Standard Serial Numbers (ISSN): 1651226X, 0284186X.


What's the best quartile of the Acta Oncologica?

The best quartile for the Acta Oncologica is Q1 (2022).


What's the coverage history of the Acta Oncologica?

The Acta Oncologica coverage history can be summarized as follows: 1963-1966, 1968-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Current Sociology journal 6591 SAGE Publications Ltd 76 2.29
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
International Journal of Mathematical Education in Science and Technology journal 10040 Taylor and Francis Ltd. 39 1.33
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Syntax journal 3422 Wiley-Blackwell Publishing Ltd 29 0.93
Transnational Corporations journal 6120 UNCTAD United Nations Conference on Trade and Development 27 1.92
Libyan Studies journal 16122 Cambridge University Press 8 0.45
Korean Journal of Applied Microbiology and Biotechnology journal 22033 Korean Society for Applied Microbiology 0 0.00

Check complete list




Year wise Impact Score (IS) of Acta Oncologica

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.36
2021 2.83
2020 2.74
2019 3.07
2018 2.70
2017 2.93
2016 2.65
2015 3.29
2014 2.55



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Radiology, Nuclear Medicine and Imaging

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

Radiology
Radiological Society of North America Inc. | United States

Cancer Treatment Reviews
W.B. Saunders Ltd | United Kingdom

Medical Image Analysis
Elsevier | Netherlands

European urology oncology
Elsevier BV | Netherlands

Ultrasound in Obstetrics and Gynecology
John Wiley and Sons Ltd | United Kingdom

Radiology: Artificial Intelligence
Radiological Society of North America Inc. | United States

Investigative Radiology
Lippincott Williams and Wilkins Ltd. | United States

European Heart Journal Cardiovascular Imaging
Oxford University Press | United Kingdom

Journal of Cardiovascular Magnetic Resonance
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All